- Home
- ALM vs OCS Comparison
ALM vs OCS Comparison
Compare ALM & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALM
- OCS
- Stock Information
- Founded
- ALM N/A
- OCS 2003
- Country
- ALM Canada
- OCS Switzerland
- Employees
- ALM N/A
- OCS N/A
- Industry
- ALM Other Metals and Minerals
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- ALM Basic Materials
- OCS Health Care
- Exchange
- ALM Nasdaq
- OCS Nasdaq
- Market Cap
- ALM 958.4M
- OCS 956.4M
- IPO Year
- ALM N/A
- OCS N/A
- Fundamental
- Price
- ALM $3.76
- OCS $17.70
- Analyst Decision
- ALM
- OCS Strong Buy
- Analyst Count
- ALM 0
- OCS 3
- Target Price
- ALM N/A
- OCS $35.33
- AVG Volume (30 Days)
- ALM 1.5M
- OCS 14.1K
- Earning Date
- ALM 08-14-2025
- OCS 08-26-2025
- Dividend Yield
- ALM N/A
- OCS N/A
- EPS Growth
- ALM N/A
- OCS N/A
- EPS
- ALM N/A
- OCS N/A
- Revenue
- ALM $20,120,360.00
- OCS $847,333.00
- Revenue This Year
- ALM $175.95
- OCS $10.23
- Revenue Next Year
- ALM $85.57
- OCS $912.87
- P/E Ratio
- ALM N/A
- OCS N/A
- Revenue Growth
- ALM 24.46
- OCS N/A
- 52 Week Low
- ALM $3.16
- OCS $10.79
- 52 Week High
- ALM $5.50
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- ALM N/A
- OCS 41.73
- Support Level
- ALM N/A
- OCS $17.27
- Resistance Level
- ALM N/A
- OCS $18.57
- Average True Range (ATR)
- ALM 0.00
- OCS 0.53
- MACD
- ALM 0.00
- OCS 0.01
- Stochastic Oscillator
- ALM 0.00
- OCS 35.56
About ALM Almonty Industries Inc. Common Shares
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.